‘Diet and lifestyle’ in the management of dyslipidaemia and prevention of CVD - Understanding the level of knowledge and interest of European Atherosclerosis Society members

Atherosclerosis Supplements - Tập 42 - Trang e9-e14 - 2020
Elke A. Trautwein1, Alberico L. Catapano2, Lale Tokgözoğlu3
1Trautwein Consulting, Hagen, Germany
2Department of Pharmacological and Biomolecular Sciences, University of Milan, And IRCCS Multimedia, Milan, Italy
3Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey

Tài liệu tham khảo

2017 Wilkins, 2017 Mach, 2019, ESC Scientific Document Group .2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk, Eur Heart J Ference, 2017, Low density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel, Eur Heart J, 38, 2459, 10.1093/eurheartj/ehx144 Piepoli, 2016, Eur Heart J, 37, 2315, 10.1093/eurheartj/ehw106 Eckel, 2014, Circulation, 129, S76, 10.1161/01.cir.0000437740.48606.d1 Kotseva, 2016, European Journal of Preventive Cardiology, 23, 2007, 10.1177/2047487316667784 Kotseva, 2019, on behalf of the EUROASPIRE Investigators. Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry, Eur J Prev Cardiol, 26, 824, 10.1177/2047487318825350 Marques-Vidal, 2020, Dietary measures among patients with coronary heart disease in Europe. ESC EORP Euroaspire V, Intern J Cardiol, 302, 5, 10.1016/j.ijcard.2019.12.064